5 Possible Therapeutic Benefits Of Cannabidiol Backed By Science

5 Possible Therapeutic Benefits Of Cannabidiol Backed By Science

Cannabidiol, commonly known as CBD, is one of the biggest new attention-getters to spring out of the movement for medical marijuana. CBD is a non-psychoactive compound found in cannabis, the sensible, useful cousin of THC. CBD’s effects as a medicine have been studied carefully, and it’s been shown to hold promise for people suffering from illnesses as diverse as cancer and neurological disease. What is this new “miracle compound” and how does it work?

CBD is just one of over 80 chemically-active compounds found in cannabis. Like any chemical compound with medical effects, it operates by interacting with specific parts of the human body. In CBD’s case, these are CB1 and CB2 receptors found in the nervous system and the immune system. In notable contrast to the more well-known THC, CBD does not bind to CB1 and CB2 receptor sites located in the brain. This means simply that it does not get people high.

CBD levels vary from strain to strain of marijuana. Selective breeding has been used to specialize different crops for different purposes. Recreational marijuana is bred to maximize THC, while industrial hemp plants are deficient in it. Today, medical marijuana plants are being bred to optimize the amount of CBD they provide. While CBD does not have an intoxicating effect on the human mind, research is starting to suggest that it has other neurological effects and that their active natures make the compound therapeutically useful.

Here are key avenues for the therapeutic use of CBD that have already received scientific study to verify their validity:

1) Treating Anxiety

Studies have shown that CBD treatment is effective in treating both stress and anxiety, reducing their impact in both a behavioral (psychological) and physiological way. According to a 2011 study in Neuropsychopharmacology, CBD had a measurable effect on regional cerebral blood flow. The patients in the study were suffering from Social Anxiety Disorder. Taking a dose of CBD resulted in immediate and significant reductions in anxiety and enhancement of their cognitive and communication skills. These results strongly imply that taking a dose of CBD is an excellent remedy for performance anxiety, e.g. the fear of public speaking.

2) Treating Addiction

Drug addiction is a complex problem with psychological and physical dimensions to consider. A key challenge in treating addiction is overcoming the compulsion to use drugs. In 2013, Addictive Biology published an animal study showing that CBD may inhibit the “reward” response of morphine usage. CBD administered to lab rats in the study made morphine less pleasurable, reducing or eliminating its addictive effects.

3) Treating Cancer

CBD has a potent ability to reduce nausea and pain and keep patients’ appetites healthy while they’re undergoing conventional treatment for cancer. Evidence also suggests that CBD may have a direct negative impact on the growth of tumors. The compound slows tumor growth, reduces cancer cell viability, and inhibits metastasis. This may be because of CBD’s anti-inflammatory and antioxidant properties. Further research is required to explore these effects in human patient

4) Treating Pain

There have been several studies exploring the efficacy of treating neuropathic pain (from cancer pain to rheumatoid arthritis) with cannabinoids. Canada has approved the use of CBD to manage pain in cancer and MS patients who do not respond to opioid therapy. So far, it is unclear whether the analgesic effect is caused primarily by CBD and whether THC helps or hinders the analgesic process.

5) Treating Seizures

CBD’s ability to mitigate the severity of seizures has already been verified in animal studies. There is a growing body of anecdotal support and case studies that point to the compound as an effective treatment for children suffering from drug-resistant epilepsy. Research needs to be conducted on a larger scale to confirm the efficacy of this treatment.

Though CBD’s therapeutic benefits are full of promise, the story of studying and unlocking its full potential has only just begun.

So the FDA makes certain that we can not make claims so like the post is title “5 possible” however we would like to point out the very CLEAR following claims by the United States government and their own Patent on CBD Oil

The Link Between “Cannabidiol” And “Cannabis”: Not A Coincidence
Marijuana is typically called “cannabis” when it’s being discussed in a medical context. However what people fail to understand is that Marijuana breed and industrial Hemp birds are different. Once is legal and one is not. The industrial hemp plant is legal to grow in an at a federal level due to the 2014 Farm Bill 7606.

What is a farm bill? The Agricultural Act of 2014 aka the Farm Bill is an omnibus legislation passed by the United States Congress. Farm Bills are passed about every five years, creating and reauthorizing federal programs in some different interests. On February 7, 2014, President Obama signed the Farm Bill of 2013 into law. Section 7606 of the act, Legitimacy of Industrial Hemp Research, defines industrial hemp as distinct from marijuana and authorizes institutions of higher education or state department’s of agriculture in states that legalized hemp cultivation to regulate and conduct research and pilot programs. Under this law, a product of the plant can be used and processed as long as the THC (psychotropic aspect) levels are no more than 0.3%. The reason industrial hemp is so popular is it contains low TCH and high compounds of whats called Cannabinoids. Particularly one called CBD (Cannabidiol) and in many governmental studies, including the government’s patent #6630507.

The governments patent states the following:
Cannabinoids as Antioxidants and Neuroprotectants
“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.”…

Inventors: Hampson; Aidan J. (Irvine, CA), Axelrod; Julius (Rockville, MD), Grimaldi; Maurizio (Bethesda, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Family ID: 26767641
Appl. No.: 09/674,028
Filed: February 2, 2001
PCT Filed: April 21, 1999
PCT No.: PCT/US99/08769
PCT Pub. No.: WO99/53917
PCT Pub. Date: October 28, 1999